Holen Sie sich die Stockscreener-App
4.48
1.13%
0.05
Handel nachbörslich:
4.58
0.10
+2.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$4.43
Offen:
$4.48
24-Stunden-Volumen:
1.71M
Relative Volume:
0.78
Marktkapitalisierung:
$1.67B
Einnahmen:
$10.53B
Nettoeinkommen (Verlust:
$-1.23B
KGV:
-1.3802
EPS:
-3.246
Netto-Cashflow:
$949.99M
1W Leistung:
-4.27%
1M Leistung:
-5.88%
6M Leistung:
-21.68%
1J Leistung:
-33.83%
1-Tages-Spanne:
$4.469
$4.60
1-Wochen-Bereich:
$4.33
$4.70
52-Wochen-Spanne:
$4.33
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
4.48 | 1.65B | 10.53B | -1.23B | 949.99M | -3.246 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Bausch Health Companies Inc expected to post earnings of $1.04 a shareEarnings Preview - TradingView
Bausch Health (TSX:BHC) Maps Out A Fresh Pharma Roadmap - Kalkine Media
Bausch Health Companies Inc (BHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bausch Health Companies Inc (BHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zacks Research Cuts Earnings Estimates for Bausch Health Cos - MarketBeat
Bausch Health Companies Inc - TradingKey
Healthcare of Ontario Pension Plan Trust Fund Sells 452,119 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
BHC|Bausch Health Companies Inc|Price:4.430|Chg%:-0.015 - TradingKey
Bausch Health Companies Inc (BHC) Institutional Confidence - TradingKey
Bausch Health Cos (NYSE:BHC) Upgraded by Jefferies Financial Group to Hold Rating - MarketBeat
Why Bausch Health (TSX:BHC) Draws Fresh Attention Today? - Kalkine Media
Bausch Health stock trades steadily as debt reduction and Xifaxan growth shape the outlook - Ad-hoc-news.de
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9 - Moomoo
Bausch Health Poised to Report Q2 Consolidated Revenue of $2.73 Billion, RBC Capital Markets Says - Moomoo
Bausch Health (TSX:BHC) Charts Fresh Pharma Roadmap - Kalkine Media
Bausch Health Cos (NYSE:BHC) Reaches New 52-Week LowShould You Sell? - MarketBeat
Bausch Health Companies stock hits 52-week low at $4.56 By Investing.com - Investing.com South Africa
Bausch Health Companies stock hits 52-week low at $4.56 - Investing.com
Bausch Health Companies Inc. (BHC) Stock Analysis: Potential 58% Upside Draws Investor Attention - DirectorsTalk Interviews
Bausch Health (NYSE: BHC) exec has 5,260 shares withheld for taxes - Stock Titan
Bausch + Lomb launches AI-powered digital health platform By Investing.com - Investing.com Nigeria
Bausch Health stock holds as debt and revenue metrics stay central - AD HOC NEWS
BHC4928364 Bond Profile — Key Metrics - TradingView
Bausch Health (NYSE: BHC) withholds 23,395 shares for RSU tax obligations - Stock Titan
Bausch Health Companies (TSX:BHC) Charts Pharma Path - Kalkine Media
Bausch + Lomb launches EyeGility IOL delivery system in U.S. By Investing.com - Investing.com Australia
BHC4986567 Bond Profile — Key Metrics - TradingView
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States - Financial Times
Bausch + Lomb launches EyeGility IOL delivery system in U.S. - Investing.com UK
Bausch Health Companies (NYSE: BHC) CAO reports 3,125-share tax withholding - Stock Titan
BHC5524410 Bond Profile — Key Metrics - TradingView
Why Is Bausch Health Companies (TSX:BHC) Back In Focus? - Kalkine Media
Bausch Health’s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary - Yahoo Finance
Bausch Health stock reflects a complex turnaround story for investors - AD HOC NEWS
WELL Health Technologies (TSX:WELL) Anchors Digital Health Market Watch - Kalkine Media
Bausch Health: Can BHC Execute a Drop Down Transaction to Refinance BHC First Lien Bonds? - CreditSights
Bausch + Lomb halts glaucoma eye drop program after trial miss - Investing.com UK
Bausch + Lomb launches AI-powered digital health platform - Investing.com
Bausch Health Companies updates its path in pharmaceuticals as investors watch broader sector trends - ad-hoc-news.de
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China - AOL.com
Migraine Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | GlaxoSmithKline, Merck, Pfizer, Bausch Health, Amgen, Abbvie, AstraZeneca, Eli Lilly - Barchart.com
Bausch Health Charts Its Next Move In Specialty Pharma - Kalkine Media
Bausch Health Companies Inc. - Baystreet.ca
Stocks in play: Bausch Health Companies Inc. - The Globe and Mail
Bausch Health plans July 29 call for Q2 results and business update - Stock Titan
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 - Moomoo
Bausch Health to report Q2 2026 earnings on Jul... - Pluang
BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.
Bausch Health Continues Specialty Pharma Strategy In 6 July 2026 - Kalkine Media
Why Did Bausch Health (TSX:BHC) Announce a Board Change? - Kalkine Media
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia - PR Newswire Canada
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.30%
2.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):